Real-World Evidence 2022: a sneak peek with Richard White

In the run up to Real-World Evidence Live: Rare Diseases and Innovative Therapies (London, UK; 29–30 June 2022), we’re giving you a preview of what you can experience at the event, including core themes such as reimbursement, machine learning and patient-first practices. One of our speakers, Richard White (Oxford PharmaGenesis), has sat down with us to talk about his upcoming feature, ‘Achieving transparency in the generation and utilization of real-world evidence (RWE)’, which you can watch on day 2 of Real-World Evidence Live 2022. Richard White is Chief Operating Officer at Oxford PharmaGenesis, a global, independent HealthScience communications consultancy. In...